(Q39210681)

10 September 2017

title

Blockade of B-cell-activating factor signaling enhances hepatic steatosis induced by a high-fat diet and improves insulin sensitivity (English)

1 reference

10 September 2017

1 reference

Keitarou Kawasaki

1

1 reference

10 September 2017

Masanori Abe

2

1 reference

10 September 2017

Fujimasa Tada

3

1 reference

10 September 2017

Yoshio Tokumoto

4

1 reference

10 September 2017

Shiyi Chen

5

1 reference

10 September 2017

Teruki Miyake

6

1 reference

10 September 2017

Shinya Furukawa

7

1 reference

10 September 2017

Bunzo Matsuura

8

1 reference

10 September 2017

Yoichi Hiasa

9

1 reference

10 September 2017

Morikazu Onji

10

1 reference

10 September 2017

publication date

14 January 2013

1 reference

10 September 2017

published in

Laboratory Investigation

1 reference

10 September 2017

volume

93

1 reference

10 September 2017

issue

3

1 reference

10 September 2017

page(s)

311-321

1 reference

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Obesity, inflammation, and liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Inflammatory links between obesity and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

B cell-activating factor controls the production of adipokines and induces insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Evaluating the glucose tolerance test in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Deletion of interleukin-6 improves pyruvate tolerance without altering hepatic insulin signaling in the leptin receptor-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

CRTC3 links catecholamine signalling to energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

BAFF: a fundamental survival factor for B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of Fatty liver inflammation in obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

7 January 2021

B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

7 January 2021

Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

7 January 2021

Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

7 January 2021

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

7 January 2021

Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.176

7 January 2021

10.1038/LABINVEST.2012.176

Identifiers

DOI

1 reference

10 September 2017

1 reference